Literature DB >> 15791393

Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.

V Herzig1, W J Schmidt.   

Abstract

In addiction research, the conditioned place preference (CPP) paradigm is a widely used animal model of conditioned reward. Usually, CPP development is studied, while only few studies examine CPP expression. In the present study, the suitability of a schedule allowing repeated testing of CPP expression was evaluated. Two groups of rats were either conditioned with cocaine or morphine then the repeated-testing-schedule was applied. This schedule consisted of four repeated applications of a sequence of drug- (i.e. cocaine or morphine), saline- and anti-craving-drug- (i.e. acamprosate, naloxone, their joint administration or saline as internal control) tests. Methodologically, the repeated-testing-schedule produced stable CPP expression in both groups over 12 subsequent tests. In conclusion, it is suggested as a useful method to study effects of anti-craving-drugs on CPP expression, thereby reducing the overall number of experimental animals. The evaluation of the anti-craving-drug effects revealed that neither acamprosate and naloxone given separately nor their combined administration significantly reduced cocaine- or morphine-CPP expression. Thus, we suggest that these anti-craving-drugs are unlikely to be effective for relapse prevention in cocaine- or morphine-addicts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791393     DOI: 10.1007/s00726-005-0185-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  2 in total

1.  Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats.

Authors:  D R Staub; J W Lunden; A M Cathel; E L Dolben; L G Kirby
Journal:  Psychoneuroendocrinology       Date:  2011-11-01       Impact factor: 4.905

2.  Biphasic effects of naloxone in the rats receiving morphine overdose a place preference study.

Authors:  Sara Karimi; Manizheh Karami; Homeira Zardooz; Seyed Hassan Salimi; Hedayat Sahraei
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.